BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Rating)’s share price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $2.55 and traded as low as $2.13. BiondVax Pharmaceuticals shares last traded at $2.18, with a volume of 19,627 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on BiondVax Pharmaceuticals in a research note on Thursday, February 9th. They set a “hold” rating on the stock.
BiondVax Pharmaceuticals Stock Performance
The firm has a market capitalization of $4.08 million, a P/E ratio of -0.54 and a beta of 2.49. The stock has a fifty day simple moving average of $2.55 and a two-hundred day simple moving average of $6.17. The company has a debt-to-equity ratio of 5.92, a current ratio of 5.76 and a quick ratio of 5.76.
Institutional Inflows and Outflows
BiondVax Pharmaceuticals Company Profile
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.
- Get a free copy of the StockNews.com research report on BiondVax Pharmaceuticals (BVXV)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for BiondVax Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiondVax Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.